Low dose DTIC is effective and safe in pretreated patients with well differentiated neuroendocrine tumors

por Mueller, Daniela, Krug, Sebastian, Majumder, Moushumee, Rinke, Anja, Gress, Thomas Matthias
Publicado 2016

Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms – Predictive and Prognostic Markers for Treatment Stratification

por Krug, Sebastian, Boch, Michael, Daniel, Hanna, Nimphius, Wilhelm, Müller, Daniela, Michl, Patrick, Rinke, Anja, Gress, Thomas Matthias
Publicado 2015

Multicenter Analysis of Presacral Neuroendocrine Neoplasms—Clinicopathological Characterization and Treatment Outcomes of a Rare Disease

por Matrood, Sami, Apostolidis, Leonidas, Schrader, Jörg, Krug, Sebastian, Lahner, Harald, Ramaswamy, Annette, Librizzi, Damiano, Kender, Zoltan, Kröcher, Anke, Kreutzfeldt, Simon, Gress, Thomas Matthias, Rinke, Anja
Publicado 2021

Treatment Approaches and Outcome of Patients with Neuroendocrine Neoplasia Grade 3 in German Real-World Clinical Practice

por Luecke, Simone, Fottner, Christian, Lahner, Harald, Jann, Henning, Zolnowski, Dominik, Quietzsch, Detlef, Grabowski, Patricia, Cremer, Birgit, Maasberg, Sebastian, Pape, Ulrich-Frank, Mueller, Hans-Helge, Gress, Thomas Matthias, Rinke, Anja
Publicado 2022